In the registration statement filed with the SEC, DrugsUSA stated that it had three different medicines approved by the Food and Drug Administration (FDA). In reality, DrugsUSA had filed applications for approval with the FDA that were still pending. The SEC approved the sale of DrugsUSA stock, and Marilyn purchased $100,000 worth of stock. Two months later, all three of DrugsUSA's applications were denied by the FDA. The stock price plummeted, reducing the value of Marilyn's shares to a total of $2,000. What, if anything, can Marilyn recover

In the given case, the default is done by the FDA and not the producing company, hence, the company in loss is eligible for the loss they have occurred. As per the laws in United states, any entity losing any profits or incurring any loss due to actions of some government entity will be eligible to that extent of loss or reduce in value. Therefore, Marilyn is eligible to recover the loss in value, that is $98000, from food and drug administration.